4Se-Kyung OH,Kimberly F,Pradip D,et al.Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy[J] Clin Biochem 2000,33(4)255-262.
5Shi QW,Ling MF,Zheng X C,et al.Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays[J].Clinical Chemistry,1999,451018-1025.
6Katrukha A G, Bereznikova A V,Filatov V L,et al.Degradation of cardiac troponin I:implication for reliable immunodetection[J].Clin Chem,1998,44(12)2433-2440.
7Giuliani I,Berinchant J P,Granier C,et al.Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia[J].Clin Chem,1999,45213-222.
8Liu S,Zhang MY,Song Q,et al.Recombinant single chain cardiac troponin I-C polypeptides:superior calibration and control materials for cardiac troponin I immunoassays[J].Clin Lab,2001,47(1-2)19-27.
9Larue C,Calzolari C,Bertinchant J,et al.Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction[J].Clin Chem,1993,39972-979.
10Apple F S,Henry T D,Berger C R,et al.Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolitic therapy[J].Am J Clin Pathol,1996,105(1)6-10.
7Mario Marzilli, Enrico Orsini, Paolo Marraccini, et al. Beneficial Effects of Intracoronary Adenosine as an Adjunct to Primary Angioplasty in Acute Myocardial Infaretion[J ]. Circulation, 2000, 101: 2154.
8Robert A, Mervyn B, Raymond J, et al. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial[J ]. European Heart Journal, 2006, 27(20) : 2400.
9Feldman L J, Coste P, Furber A, et al. Incomplete resolution of ST segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction [J]. Circulation, 2003, 107(21): 2684.
10Assali A R, Sdringola S, Ghani M, et al. Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of no reflow phenomenon [ J ]. Catheter and Cardiovasc Interv, 2000, 51(1): 27.
